RETINALGENIX TECHNOLOGIES INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-2.4M | $-4.3M | $-2.1M | $-3.9M | $-2.2M | $-2.1M |
| Depreciation & Amortization | — | — | — | — | — | — |
| Depreciation | $56 | $100 | $100 | $51 | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $1.0M | $2.6M | $664.2K | $259.3K | $307.9K | $220.2K |
| Net Cash from Operating Activities | $-558.4K | $-741.9K | $-451.7K | $-199.3K | $-1.2M | $-1.4M |
| Investing Activities | ||||||
| Capital Expenditures | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $567.1K | $748.0K | $451.6K | $194.7K | $1.2M | $1.4M |
| Net Change in Cash | $8.7K | $6.1K | $-38 | $-4.9K | $2.7K | $-52.2K |
| Free Cash Flow | — | — | — | — | — | — |